You are here

Tafinlar

Daiichi Sankyo unit claims $182m in Novartis patent dispute

Pharmaphorum

Wed, 12/6/23 - 10:31 am

Novartis' Tafinlar/Mekinist combo scores new indication in pediatric brain cancer

Endpoints

Sun, 03/19/23 - 01:36 pm

Novartis Combo could be New Standard of Care for Pediatric Glioma Patients

BioSpace

Wed, 06/8/22 - 10:42 am

clinical trials

Novartis to pay nearly $178M in lawsuit over BRAF drug — and will be on the hook for royalty

Endpoints

Fri, 07/23/21 - 10:57 am

FDA approves Novartis combo therapy for aggressive type of thyroid cancer

Reuters

Fri, 05/4/18 - 06:53 pm

anaplastic thyroid cancer

FDA adds fresh ‘breakthrough’ for Novartis’ cancer combo Tafinlar and Mekinist

Endpoints

Mon, 10/23/17 - 09:57 am

non-small cell lung cancer

Novartis picks up FDA approval for targeted lung cancer meds Tafinlar, Mekinist

Fierce Pharma

Fri, 06/23/17 - 03:35 pm

non-small cell lung cancer

Novartis' targeted meds Tafinlar, Mekinist pick up EU combo approval in lung cancer

Fierce Pharma

Wed, 04/5/17 - 12:07 pm

Novartis' Lung Cancer Drug Combo Gets EU Nod

Investopedia

Mon, 04/3/17 - 09:19 am

metastatic non-small cell lung cancer

Novartis nabs EU approval for melanoma-fighting cocktail bought from GSK

Fierce Pharma

Tue, 09/1/15 - 06:35 pm

Novartis melanoma drug combination wins EU green light

Yahoo/Reuters

Sat, 07/25/15 - 09:38 am

Post-swap Novartis preps cancer drug R&D road show

Fierce Biotech

Wed, 05/27/15 - 11:26 am

Melanoma Treatment Battle Between Roche And GSK Heats Up

Bidness Etc.

Tue, 09/30/14 - 06:27 pm

GSK melanoma pill backed by UK cost watchdog with price cut

Yahoo/Reuters

Thu, 09/18/14 - 08:59 am

Study: GlaxoSmithKline's Mekinist, Tafinlar combination shows survival benefit versus Roche's Zelboraf in melanoma

First Word Pharma

Thu, 07/17/14 - 10:12 am

GSK melanoma drug combination faces delay in Europe

Yahoo/Reuters

Wed, 03/26/14 - 08:01 am

GlaxoSmithKline and Personalized Medicine Take Another Leap Forward

Motley Fool

Mon, 01/27/14 - 12:18 pm

personalized medicine

GSK says melanoma combination meets main goal

Reuters

Fri, 01/24/14 - 12:15 pm

GlaxoSmithKline nabs 'breakthrough' label for Tafinlar in lung cancer

Fierce Pharma

Tue, 01/14/14 - 08:27 am

breakthrough therapies

GSK melanoma drug combination wins accelerated U.S. approval

Yahoo/Reuters

Thu, 01/9/14 - 08:37 am

Pages